Comparison of the upper and lower airway microbiota in children with chronic lung diseases

Bushra Ahmed1,2, Michael J Cox1, Leah Cuthbertson1

  • 1National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Plos One
|August 3, 2018
PubMed

Insights

Throat swabs (TS) can reflect lower airway microbiota in children with chronic lung diseases (CLDs). While TS show community structure, they are not suitable for clinical decisions in pediatric respiratory health.

Area of Science:

  • Pediatric Pulmonology
  • Microbiome Research
  • Immunological Development

Background:

  • The lower airway microbiota plays a crucial role in immune development and chronic lung diseases (CLDs).
  • Limited longitudinal studies exist for pediatric lower airway microbiota due to difficulties in sample collection from young children.
  • Uncertainty remains regarding the representativeness of upper airway samples for the lower airway microbiota.

Purpose of the Study:

  • To evaluate if throat swabs (TS) and cough swabs (CS) accurately represent the lower airway microbiota in children.
  • To determine the utility of non-invasive upper airway samples for studying pediatric respiratory microbiota.

Main Methods:

  • Prospective collection of throat swabs (TS), cough swabs (CS), bronchoalveolar lavage (BALF), and bronchial brushings from 49 children with CLDs.
  • Bacterial DNA extraction and 16S rRNA gene sequencing (V4 region) using Illumina MiSeq.
  • Comparative analysis of microbial community structure (alpha and beta diversity) and relative abundance.

Main Results:

  • High-quality sequencing reads were obtained from 168 samples.
  • Cough swabs (CS) demonstrated poor sequencing performance.
  • Throat swabs (TS) showed no significant difference in alpha diversity compared to lower airway samples.
  • Beta diversity variation attributed to sampling method for TS was minimal (<6.31%), significantly less than variation due to pathology or individual patients.
  • Strong correlation in the relative abundance of bacterial genera between TS and lower airway samples (r=0.78).

Conclusions:

  • Throat swabs (TS) demonstrate community-level correlation with lower airway microbiota in children.
  • TS can distinguish between different chronic lung diseases (CLDs) based on respiratory microbiota profiles.
  • TS may serve as a valuable non-invasive tool for longitudinal studies of pediatric respiratory microbiota in CLDs, but are not suitable for clinical decision-making.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
667